Al-Kadmy Israa M S, Aziz Sarah Naji, Rheima Ahmed Mahdi, Abid Suhad Abbas, Suhail Ahmed, Hamzah Israa Hussein, Naji Eman N, Besinis Alexandros, Hetta Helal F
Branch of Biotechnology, Department of Biology, College of Science, Mustansiriyah University, POX 10244, Baghdad, Iraq.
Branch of Microbiology, Department of Biology, College of Science, Mustansiriyah University, POX 10244, Baghdad, Iraq.
Microb Pathog. 2023 Aug;181:106184. doi: 10.1016/j.micpath.2023.106184. Epub 2023 Jun 5.
Copper oxide nanoparticles are modern kinds of antimicrobials, which may get a lot of interest in the clinical application. This study aimed to detect the anti-capsular activity of CuO nanoparticles against Acinetobacter baumannii produce efflux pump. Thirty-four different clinical A. baumannii isolates were collected and identified by the phenotypic and genetic methods by the recA gene as housekeeping. Antibiotic sensitivity and biofilm-forming ability, capsular formation were carried out. The effect of CuO nanoparticles on capsular isolates was detected, the synergistic effects of a combination CuO nanoparticles and gentamicin against A. baumannii were determined by micro broth checkerboard method, and the effect of CuO nanoparticles on the expression of ptk, espA and mexX genes was analyzed. Results demonstrated that CuO nanoparticles with gentamicin revealed a synergistic effect. Gene expression results show reducing the expression of these capsular genes by CuO nanoparticles is major conduct over reducing A. baumannii capsular action. Furthermore, results proved that there was a relationship between the capsule-forming ability and the absence of biofilm-forming ability. As bacterial isolates which were negative biofilm formation were positive in capsule formation and vice versa. In conclusion, CuO nanoparticles have the potential to be used as an anti-capsular agent against A. baumannii, and their combination with gentamicin can enhance their antimicrobial effect. The study also suggests that the absence of biofilm formation may be associated with the presence of capsule formation in A. baumannii. These findings provide a basis for further research on the use of CuO nanoparticles as a novel antimicrobial agent against A. baumannii and other bacterial pathogens, also to investigate the potential of CuO nanoparticles to inhibit the production of efflux pumps in A. baumannii, which are a major mechanism of antibiotic resistance.
氧化铜纳米颗粒是新型抗菌剂,在临床应用中可能备受关注。本研究旨在检测氧化铜纳米颗粒对产外排泵的鲍曼不动杆菌的抗荚膜活性。收集了34株不同的临床鲍曼不动杆菌分离株,通过表型和基因方法,以看家基因recA进行鉴定。进行了抗生素敏感性、生物膜形成能力、荚膜形成检测。检测了氧化铜纳米颗粒对荚膜分离株的作用,采用微量肉汤棋盘法测定氧化铜纳米颗粒与庆大霉素联合对鲍曼不动杆菌的协同作用,并分析了氧化铜纳米颗粒对ptk、espA和mexX基因表达的影响。结果表明,氧化铜纳米颗粒与庆大霉素显示出协同作用。基因表达结果表明,氧化铜纳米颗粒降低这些荚膜基因的表达是抑制鲍曼不动杆菌荚膜活性的主要方式。此外,结果证明荚膜形成能力与生物膜形成能力的缺失之间存在关联。因为生物膜形成阴性的细菌分离株荚膜形成阳性,反之亦然。总之,氧化铜纳米颗粒有潜力用作抗鲍曼不动杆菌的抗荚膜剂,其与庆大霉素联合可增强抗菌效果。该研究还表明,生物膜形成的缺失可能与鲍曼不动杆菌中荚膜形成的存在有关。这些发现为进一步研究氧化铜纳米颗粒作为抗鲍曼不动杆菌及其他细菌病原体的新型抗菌剂提供了依据,也为研究氧化铜纳米颗粒抑制鲍曼不动杆菌外排泵产生的潜力提供了依据,外排泵是抗生素耐药的主要机制。